Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reelin-immunoreactive neurons in the adult vertebrate pallium.

Journal of chemical neuroanatomy·2001

Same author

Ionic films on vicinal metal surfaces: enhanced binding due to charge modulation.

Physical review letters·2001

Same author

Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.

The American journal of medicine·2001

Same author

Structure and mesomorphism of neodymium(III) alkanoates.

Inorganic chemistry·2001

Same author

[Trabeculotomy in congenital glaucoma: comparison to goniotomy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2001

Same author

Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves.

Vaccine·2001

Search research articles

Related Experiment Video

Updated: May 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Evidence base in guideline generation in diabetes.

I Mühlhauser¹, G Meyer

¹Unit of Health Sciences and Education, University of Hamburg, Martin-Luther-King Platz 6, 20146, Hamburg, Germany. Ingrid_Muehlhauser@uni-hamburg.de

|March 12, 2013

Summary

Clinical practice guidelines (CPGs) vary in quality, often lacking patient-centeredness and clear decision-making information. Financial conflicts of interest (COI) are prevalent, necessitating independent methodologists for guideline development.

Related Experiment Videos

Last Updated: May 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Area of Science:

Medical Informatics
Health Services Research
Evidence-Based Medicine

Background:

Clinical practice guidelines (CPGs) are crucial for evidence-based medicine but exhibit significant variability in methodological quality.
Key contemporary concerns include patient-centeredness, shared decision-making, and financial conflicts of interest (COI) in CPG development.

Purpose of the Study:

To critically evaluate patient-centeredness and COI in current CPGs.
To identify areas for improvement in CPG development to enhance clinical applicability and patient benefit.

Main Methods:

Review of current literature and practices concerning CPG development.
Analysis of patient involvement strategies and conflict of interest policies in CPGs.

Main Results:

CPGs often fail to meet patient needs by not providing accessible summaries of treatment benefits and risks.
A majority of CPG panels report financial COI, with frequent under-reporting and inconsistent organizational policies.
Current patient involvement methods do not fully substitute for individual patient preferences in clinical decisions.

Conclusions:

Enhancing patient-centeredness and transparency regarding COI are critical for improving CPG quality.
Independent methodologists and shared data platforms (e.g., EASD clearing house) are recommended to mitigate bias and resource waste in CPG development.